Format

Send to

Choose Destination
Technol Cancer Res Treat. 2010 Dec;9(6):589-96.

CyberKnife stereotactic ablative radiotherapy for lung tumors.

Author information

1
Department of Radiation Oncology Stanford University and Cancer Center 875 Blake Wilbur Drive, MC 5847 Stanford, CA 94305-5847, USA. iris.gibbs@stanford.edu

Abstract

Stereotactic ablative radiotherapy (SABR) has emerged as a promising treatment for early stage non-small cell lung cancer, particularly for patients unable to tolerate surgical resection. High rates of local tumor control have been demonstrated with acceptable toxicity and the practical advantage of a short course of treatment. The CyberKnife image-guided robotic radiosurgery system has unique technical characteristics that make it well suited for SABR of tumors that move with breathing, including lung tumors. We review the qualities of the CyberKnife platform for lung tumor SABR, and provide a summary of clinical data using this system specifically.

PMID:
21070081
DOI:
10.1177/153303461000900607
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center